Satol, Basit S.

HRN: 09-91-44  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2022
CEFTAZIDIME 1GM (VIAL)
04/25/2022
05/02/2022
IV
1g
Q8H
Pneumonia
Waiting Final Action 
05/03/2022
CO-AMOXICLAV 625MG (TAB)
05/03/2022
05/10/2022
PO
625mg
TID
CAP-MR
Waiting Final Action 
11/10/2022
CEFTRIAXONE 1G (VIAL)
11/10/2022
11/16/2022
IVT
2 G
Once A Day
Acute Cystitis
Waiting Final Action 
11/20/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/20/2022
11/27/2022
IV
900 Mg
OD
Cathether Associated UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: